IMMUNOGENIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

Provided herein are compositions and methods for eliciting an immune response in a subject. In particular, the present disclosure is directed to immunogenic fusion proteins and methods of eliciting an immune response using host cells comprising nucleic acid molecules encoding said fusion proteins.

Saved in:
Bibliographic Details
Main Authors DRAKE, CHARLES G, FASSO, MARCELLA, BROCKSTEDT, DIRK G, HANSON, WILLIAM G, RAE, CHRISTOPHER STEVEN, LAUER, PETER M, LEONG, MEREDITH LAI LING
Format Patent
LanguageEnglish
French
Published 20.10.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are compositions and methods for eliciting an immune response in a subject. In particular, the present disclosure is directed to immunogenic fusion proteins and methods of eliciting an immune response using host cells comprising nucleic acid molecules encoding said fusion proteins.
Bibliography:Application Number: CA20162982543